Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FX4Q0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,238
Award facts
- Contract value 100% obligated
- $49,238.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $49,238.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3 mL) on February 4, 2026, with completion scheduled for February 5, 2026. The award was made on a competitive, non-set-aside basis and represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal military and veteran healthcare systems. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the primary IDC vehicle and has an established track record of supplying diverse pharmaceutical products and medical supplies across multiple therapeutic domains to DLA and other federal agencies.
This delivery order for the diabetes medication Ozempic exemplifies AmerisourceBergen's role as a critical vendor within the military healthcare supply chain, fulfilling prescription pharmaceutical needs for Defense Health Agency facilities and other federal medical institutions. The firm fixed-price structure and rapid completion timeline reflect the operational efficiency required for pharmaceutical distribution to support ongoing military healthcare operations. The award demonstrates the company's capability to meet federal procurement requirements for essential brand-name medications through open competition and its established pharmaceutical supply infrastructure.
Quick answers
Who was awarded contract SPE2DR26FX4Q0?
SPE2DR26FX4Q0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FX4Q0 worth?
The government has obligated $49,238 on SPE2DR26FX4Q0.
Is contract SPE2DR26FX4Q0 an order under another contract?
Yes. SPE2DR26FX4Q0 is a delivery order under SPE2DR25D2218, an indefinite delivery contract.
Was contract SPE2DR26FX4Q0 competed?
The extent of competition for SPE2DR26FX4Q0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award